Skip to main content
. Author manuscript; available in PMC: 2009 Sep 2.
Published in final edited form as: J Antimicrob Chemother. 2008 Mar 20;61(6):1393–1394. doi: 10.1093/jac/dkn109

Table.

Phenotypic and genotypic characteristics of the K. pneumoniae clinical isolates

Phenotypic No. of isolates
(n=270)
Antimicrobial agents a ESBLs Pulsotypes
Group Subgroup CAZ CTX FEP FOX ETP IPM CIP CHL GEN AMK
I a 155 R R R S S S R R S/I/R S/I/R CTX-M-15 A
b 71 R R I S S S R R S/I/R S/I/R CTX-M-15 A
c 18 I R S S S S R S/I/R S/R S/I/R CTX-M-15 B
d 7 S R S S/R S S I/R I/R R/S S CTX-M-15 C
e 4 R R S S S S R R R/S R/S CTX-M-15 A, B ,K , L
II - 5 R S S S S S S I/S S S SHV-12 D
III - 10 S S S S S S S I/R/S S S None miscellaneous
a

CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; FOX, cefoxitin; ETP, ertapenem; IPM, imipenem; CIP, ciprofloxacin; CHL, chloramphenicol; GEN, gentamicin; AMK, amikacin. Susceptibility results were interpreted according to the CLSI criteria: R, resistant; I, intermediate; S, susceptible.